| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Articles |
Department of Pharmacology, Cornell University Medical College, New York, New York 10021
Abstract
Using a PCR-based cDNA subtractive hybridization method (L. Diatchenko
et al., Proc. Natl. Acad. Sci. USA, 93:
60256030, 1996), we cloned a cDNA fragment of a novel gene
that is highly expressed in F9-10; F9-10 is an F9 teratocarcinoma stem
cell line that expresses high levels of exogenous Hoxa-1 mRNA and
protein in comparison to F9 wild-type stem cells, which do not express
endogenous Hoxa-1 mRNA in the absence of retinoic acid (RA). Rapid
amplification of cDNA ends was used to clone the full-length cDNA of
this gene, designated HA1R-62 (Hoxa1 regulated-62). We have shown that
HA1R-62 is also a RA-responsive gene and that it is expressed (mRNA
size,
4.3 kb) in adult mouse thymus, lung, kidney, and ovary as well
as in 12.5-day mouse embryos. DNA sequence analysis and in
vitro translation experiments have shown that HA1R-62 encodes a
protein with a molecular mass of approximately 26 kDa.
Elucidation of the function of the HA1R-62 gene product will provide
new insights into the functions of RA and homeobox genes.
This article has been cited by other articles:
![]() |
E. Martinez-Ceballos, P. Chambon, and L. J. Gudas Differences in Gene Expression between Wild Type and Hoxa1 Knockout Embryonic Stem Cells after Retinoic Acid Treatment or Leukemia Inhibitory Factor (LIF) Removal J. Biol. Chem., April 22, 2005; 280(16): 16484 - 16498. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |